Iso­Plex­is scores big backer for per­son­al­ized pro­tein 'bar­codes' as Per­cep­tive jumps on board new fund­ing round

A lit­tle less than two years af­ter bag­ging an ex­tend­ed $50 mil­lion Se­ries C, Iso­Plex­is and its “pro­teom­ic bar­codes” for per­son­al­ized can­cer care are back set­ting hooks to bring even more in­vestors on board. And this time, they’ve caught a big fish.

Per­cep­tive Ad­vi­sors is lead­ing a $135 mil­lion Se­ries D round for the com­pa­ny, the firms an­nounced Thurs­day, com­pris­ing $85 mil­lion in eq­ui­ty and a $50 mil­lion line of cred­it. Iso­Plex­is plans to use the pro­ceeds to ex­pand com­mer­cial and R&D staff, in­crease op­er­a­tional ca­pac­i­ty and ac­cel­er­ate prod­uct de­vel­op­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER